Capital Asset Advisory Services LLC Amgen Inc Transaction History

Capital Asset Advisory Services LLC

$2.01 Billion
Q3 2024

A detailed history of Capital Asset Advisory Services LLC transactions in Amgen Inc stock. As of the latest transaction made, Capital Asset Advisory Services LLC holds 2,027 shares of AMGN stock, worth $640,532. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,027

Previous 1,728 17.3%

Holding current value

$640,532

Previous $539,000 21.15%

% of portfolio

0.03%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$309.38 - $337.38 $92,504 - $100,876	299 Added 17.3%	2,027 $653,000
Q2 2024 Jul 24, 2024	SELL	$262.75 - $319.31 $8,145 - $9,898	-31 Reduced 1.76%	1,728 $539,000
Q1 2024 Apr 16, 2024	BUY	$268.87 - $324.56 $74,476 - $89,903	277 Added 18.69%	1,759 $500,000
Q4 2023 Jan 09, 2024	BUY	$255.7 - $288.46 $378,947 - $427,497	1,482 New	1,482 $426,000
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $16,031 - $19,539	-71 Reduced 4.61%	1,470 $355,000
Q4 2022 Mar 08, 2023	BUY	$229.03 - $291.01 $229 - $291	1 Added 0.06%	1,541 $404,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $11,671 - $13,163	52 Added 3.49%	1,540 $347,000
Q2 2022 Aug 11, 2022	BUY	$230.71 - $256.74 $3,922 - $4,364	17 Added 1.16%	1,488 $362,000
Q1 2022 Apr 29, 2022	BUY	$219.27 - $242.57 $8,112 - $8,975	37 Added 2.58%	1,471 $356,000
Q4 2021 Feb 04, 2022	BUY	$198.88 - $227.6 $15,114 - $17,297	76 Added 5.6%	1,434 $323,000
Q3 2021 Oct 14, 2021	SELL	$212.27 - $248.7 $497,560 - $582,952	-2,344 Reduced 63.32%	1,358 $289,000
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $39,241 - $43,535	-168 Reduced 4.34%	3,702 $902,000
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $858,791 - $1 Million	3,870 New	3,870 $963,000
Q3 2020 Nov 18, 2020	SELL	$234.65 - $260.95 $867,501 - $964,732	-3,697 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $101,080 - $124,040	511 Added 16.04%	3,697 $868,000
Q1 2020 May 18, 2020	BUY	$182.24 - $241.7 $151,988 - $201,577	834 Added 35.46%	3,186 $755,000
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $445,021 - $572,006	2,352 New	2,352 $538,000
Q2 2019 Jul 15, 2019	SELL	$166.7 - $195.41 $369,240 - $432,833	-2,215 Closed	0 $0
Q1 2019 Apr 24, 2019	SELL	$180.87 - $203.88 $3,617 - $4,077	-20 Reduced 0.89%	2,215 $421,000
Q3 2018 Jan 31, 2019	SELL	$185.29 - $208.89 $4,632 - $5,222	-25 Reduced 1.11%	2,235 $463,000
Q2 2018 Jul 11, 2018	BUY	$166.05 - $186.51 $4,981 - $5,595	30 Added 1.35%	2,260 $417,000
Q3 2017 Oct 30, 2017	BUY	$167.29 - $191.0 $373,056 - $425,930	2,230	2,230 $416,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Asset Advisory Services LLC with notifications on news.

Account

Capital Asset Advisory Services LLC Amgen Inc Transaction History